| Revenue: | |
| Product revenue | 9.73M |
| Government grants and cooperative agreements | 0 |
| Total revenue | |
| Cost of product revenue | 5.09M |
| Gross profit | 4.64M |
| Operating expenses: | |
| Research and development | |
| Selling, general and administrative | 6.85M |
| Amortization of intangible assets | 50K |
| Acquisition related costs, net | |
| Total operating expenses | 9.6M |
| Loss from operations | -4.96M |
| Non-operating income (expense): | |
| Loss from revaluation of warrant liability | -5.07M |
| Foreign exchange gain (loss) | -54K |
| Interest expense | -131K |
| Other expense, net | 17K |
| Total non-operating expense | -5.24M |
| Net loss | -10.25M |
| Net loss per common share: | |
| Basic | -0.17 |
| Diluted | -0.17 |
| Weighted average common shares outstanding used for calculating net loss per common share: | |
| Basic | 59.73M |
| Diluted | 59.73M |